
Daorid 10mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Glibenclamide (10mg)
Overview Daorid 10mg Tablet
Glycon 10mg tablets are prescribed for adult patients with type 2 diabetes. A sulfonylurea, Glycon helps regulate blood glucose, mitigating risks such as renal impairment and vision loss. This medication can be administered alone or in conjunction with other treatments and should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician based on treatment response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation may lead to hyperglycemia and complications including nephropathy, blindness, neuropathy, and limb loss. Remember, Glycon is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common adverse effects include nausea, headache, and vertigo, with hypoglycemia also possible. Learn to recognize hypoglycemic symptoms—sweating, dizziness, headache, and tremors—and know how to manage them using readily available glucose sources. Alcohol consumption should be limited due to increased hypoglycemia risk. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of cardiac issues, thyroid disorders, or hormonal imbalances before commencing treatment. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.
Primary Ingredients of Daorid 10mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Daorid 10mg Tablet
Managing Type 2 diabetes
Major Benefits of Daorid 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 10mg Daorid tablet whole; do not crush, chew, or break it. Consume with food.
Common Side effects of Daorid 10mg Tablet:
- Hypoglycemia (low blood glucose level)
- Nausea
- Headache
- Dizziness
How to use Daorid 10mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 10mg Daorid tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Daorid 10mg Tablet works:
Glycemia-10 (10mg) tablets help manage diabetes by stimulating pancreatic insulin secretion, thus reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Daorid 10mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Daorid 10mg tablets is typically deemed safe. Animal research indicates minimal or absent harm to fetal development; nonetheless, human data remain scarce.
Breast feedingSAFE IF PRESCRIBED
Daorid 10mg tablets appear safe for breastfeeding mothers. Available human data indicates minimal risk to the infant. Closely observe the nursing infant's blood glucose levels while the mother is taking Daorid 10mg tablets.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
Individuals with kidney impairment should likely avoid Daorid 10mg Tablets due to potential safety concerns. A physician's consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Daorid 10mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Daorid 10mg Tablets are contraindicated in individuals with severe hepatic dysfunction due to the risk of pronounced hypoglycemia.
What if you forget to take Daorid 10mg Tablet :
Omit a Daorid 10mg Tablet dose if a meal is missed; conversely, include an additional dose should you consume an unplanned meal.
Facts to Know About Daorid 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Second-generation sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Insulin-Stimulating Sulfonylureas |
